EUROSPINE 2017

Raphaƫle Charest-Morin

2015-present Université Laval, Centre Hospitalier Universitaire de Québec
Assistant professor and Consultant spinal orthopaedic surgeon

2014-2015 Vancouver General Hospital
University of British Columbia (UBC)
Spine fellow

Peer-reviewed Publications

Charest-Morin R, Fisher CG, Varga PP, Gokaslan ZL, Rhines LD, Reynolds JJ, Dekutoski MB, Quraishi NA, Bilsky MH, Fehlings MG, Chou D, Germscheid NM, Luzzati A, Boriani S; AOSpine Knowledge Forum Tumor. En bloc resection versus intralesional surgery in the treatment of giant cell tumor of the spine.Spine (Phila Pa 1976). 2017 Jan 31. doi:10.1097/BRS.0000000000002094.
PMID: 28146024

Dea N, Charest-Morin R, Sciubba DM, Bird JE, Disch AC, Mesfin A, Lazáry Á, Fisher CG, Ames C. Optimizing the Adverse Event and HRQOL Profiles in the Management of Primary Spine Tumors.
Spine (Phila Pa 1976). 2016 Oct 15;41 Suppl 20:S212-S217.
PMID: 27753783

Charest-Morin R, Boriani S, Fisher CG, Patel SR, Kawahara N, Mendel E, Bettegowda C, Rhines LD. Benign Tumors of the Spine: Has New Chemotherapy and Interventional Radiology Changed the Treatment Paradigm?Spine (Phila Pa 1976). 2016 Oct 15;41 Suppl 20:S178-S185.
PMID: 27488295

Flexman AM, Charest-Morin R, Stobart L, Street J, Ryerson CJ. Frailty and postoperative outcomes in patients undergoing surgery for degenerative spine disease.Spine J. 2016 Nov;16(11):1315-1323. doi: 10.1016/j.spinee.2016.06.017.
PMID: 27374110

Charest-Morin R, Dea N, Fisher CG; Health-Related Quality Of Life After Spine Surgery For Primary Bone Tumor, Curr. Teat. Options in Oncology. 2016 jan;17 9); doi : 10.1007/s11864-015-0383-z